Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
出版年份 2022 全文链接
标题
Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-02-22
DOI
10.3389/fphar.2022.837503
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
- (2021) G. Carioli et al. ANNALS OF ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma
- (2021) Yasuyuki Okada et al. CARCINOGENESIS
- The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
- (2021) Yibo Fu et al. Cells
- Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer
- (2021) Won-Ji Ryu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy
- (2021) Devesh Tewari et al. PHARMACOLOGY & THERAPEUTICS
- A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
- (2021) K. Hoyer et al. EBioMedicine
- The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
- (2021) Marwa Elsayed et al. Biomedicines
- Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
- (2021) Jakob M. Riedl et al. EUROPEAN JOURNAL OF CANCER
- Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
- (2021) Kanan Panchal et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments
- (2021) Ersilia Nigro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines
- (2021) Waisse Waissi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis
- (2021) Marko Damm et al. Cancers
- Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
- (2021) Shima Makaremi et al. Biomedicines
- Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
- (2020) Eric S Christenson et al. LANCET ONCOLOGY
- Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
- (2020) Louis Buscail et al. Nature Reviews Gastroenterology & Hepatology
- ERK/MAPK signalling pathway and tumorigenesis (Review)
- (2020) Yan‑Jun Guo et al. Experimental and Therapeutic Medicine
- AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells
- (2020) Luigi Sapio et al. Journal of Oncology
- Neoadjuvant Treatment in Pancreatic Cancer
- (2020) Atsushi Oba et al. Frontiers in Oncology
- The influence of cancer molecular subtypes and treatment on the mutation spectrum in metastatic breast cancers
- (2020) Benjamin Verret et al. CANCER RESEARCH
- Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
- (2020) Gabriel Benyomo Mpilla et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
- (2020) Yunzhen Qian et al. Journal of Hematology & Oncology
- Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
- (2020) He-Li Gao et al. Experimental Hematology & Oncology
- Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
- (2019) Hakon Blomstrand et al. BMC CANCER
- ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity
- (2019) Vinnyfred Vincent et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Molecular subtypes of pancreatic cancer
- (2019) Eric A. Collisson et al. Nature Reviews Gastroenterology & Hepatology
- Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
- (2019) Marwa Alhothali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1
- (2019) Yanan Lu et al. EBioMedicine
- Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells
- (2019) Amin A. Ramzan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Chemotherapy impacts on the cellular response to CDK4/6 inhibition: distinct mechanisms of interaction and efficacy in models of pancreatic cancer
- (2019) Vishnu Kumarasamy et al. ONCOGENE
- Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
- (2019) Anouk E.J. Latenstein et al. EUROPEAN JOURNAL OF CANCER
- AdipoRon promotes diabetic fracture repair through endochondral ossification-based bone repair by enhancing survival and differentiation of chondrocytes
- (2019) Zhongyi Wang et al. EXPERIMENTAL CELL RESEARCH
- Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death
- (2018) Ilaria Passacantilli et al. ONCOLOGY REPORTS
- Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis
- (2018) Miho Akimoto et al. Cell Death & Disease
- Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1
- (2018) Cancan Zhou et al. CELL PROLIFERATION
- Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
- (2017) Lei Huang et al. GUT
- Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor
- (2017) Ryan Montano et al. Oncotarget
- Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
- (2017) Fanuel Messaggio et al. Oncotarget
- Pancreatic Cancer Chemoresistance to Gemcitabine
- (2017) Manoj Amrutkar et al. Cancers
- Pharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer Cells
- (2016) Xin Miao et al. Frontiers in Pharmacology
- Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma
- (2016) Matthew H. Wong et al. NEOPLASIA
- Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
- (2015) Maria Teresa Esposito et al. NATURE MEDICINE
- Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer
- (2015) Toru Furukawa Frontiers in Oncology
- ABCB2 (TAP1) as the downstream target of SHH signaling enhances pancreatic ductal adenocarcinoma drug resistance
- (2013) Min Xu et al. CANCER LETTERS
- The Effects of Adiponectin and Leptin on Human Endothelial Cell Proliferation: A Live-Cell Study
- (2012) Granada Álvarez et al. JOURNAL OF VASCULAR RESEARCH
- Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways
- (2012) Anna Koskinen et al. ARTHRITIS RESEARCH & THERAPY
- VCAM-1 promoted by leptin could be offset by adiponectin through the activation of ampk via adipoR1 receptor of VECs in 3D vessel model
- (2011) Z. Zhi et al. HEART
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started